Circulus Receives FDA Letter of Non-Objection at its Riverbank, CA Facility

Clears the way for use of its post-consumer resins in food packaging

HOUSTON--(BUSINESS WIRE)--Circulus Holdings, PBLLC (Circulus), a producer of post-consumer resin (PCR) from recycled low-density polyethylene, has recently received a Letter of Non-Objection (LNO) from the U.S. Food and Drug Administration (FDA).

The LNO certifies that Circulus’ recycling process in Riverbank, CA is able to produce 100% recycled PCR suitable for direct food-contact packaging applications. Suitable food packaging applications include direct contact for room temperature, refrigerated, and frozen goods.

David Hudson, Founder and Chief Strategy Officer of Circulus, stated, “From its inception, Circulus has been committed to the goal of producing resin for consumer-facing products and packaging. This development provides important and independent validation that we have achieved our goal, allowing us to move forward in this important market for recycled materials.”

Circulus CEO Craig Foster stated, “This is a huge step forward for Circulus, the circular economy, and for the sustainable packaging industry. Our customers want mechanically recycled resin suitable for the broadest use of applications and Circulus now has the ability to meet this demand.”

Circulus is a portfolio company of Ara Partners, a private equity firm that specializes in decarbonization investments.

About Circulus

Circulus Holdings, PBLLC is focused on the conversion of plastic waste into post-consumer resins (PCR) utilizing world-class mechanical recycling solutions. Circulus contributes to the circular economy by recycling plastics to their highest and best use while eliminating waste. The company is headquartered in Houston, Texas and currently has facilities in development across the U.S. For more information on Circulus, please visit www.circulus.com.